Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
The first three vaccines against Covid-19 approved for use in Europe were made by Pfizer, AstraZeneca and Moderna. February 2021
The first three vaccines against Covid-19 approved for use in Europe were made by Pfizer, AstraZeneca and Moderna. February 2021 - Credit: cristianstorto / DepositPhotos
Health
Coronavirus
Covid-19
coronavirus vaccine
Tuesday, 16 March 2021 - 21:20
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Some 1.4 million vaccinated against Covid-19

Nine weeks into the Covid-19 vaccination program, the Netherlands has given at least one injection to 1,394,603 people aged 18 and up. That represents about 9.7 percent of the adult population, and 8.0 percent of the entire population, according to the RIVM.

Out of that group, 493,123 have received their second dose of one of the three two-shot vaccines approved for use in the European Union. That equates to 3.4 percent of adults in the country, or 2.9 percent of everyone living in the Netherlands including children.

After the first full week of vaccinating people in their late seventies who reside at home, some 44 thousand of them have received at least one injection. There are about 629,500 of them living in the country.

Up through Sunday, about 74 percent of those in their early eighties have been partially vaccinated, and 76 percent of people in their late eighties living at home. Roughly 66 percent of everyone aged 90 and up still in their own homes have been given at least one shot.

Nearly 28 thousand more vaccine injections were given out on Monday. That brought the total number of doses delivered up to 1,915,572. Despite the suspension of use of the AstraZeneca vaccine in the Netherlands, the country was likely to cross the two-million mark some time this week.

Netherlands vaccination progress through 14 March 2021
Target Group First Dose % of 1st Dose Recipients Second Dose % of 2nd Dose Recipients
Covid-19 caregivers 40,000 2.9% 40,000 8.1%
Family doctors 14,300 1.0% 13,300 2.7%
Other care workers* 356,972 25.6% 196,083 39.8%
At-home residents        
90 and up 61,258 4.4% 34,345 7.0%
80-89 years 169,045 12.1% 47,681 9.7%
80-84 years 305,321 21.9% 5,713 1.2%
75-79 years 44,066 3.2% 572 0.1%
60-64 years at high-risk for Covid-19 154,803 11.1% 0 0.0%
Care home residents        
Larger facilities and GGD care centers 168,241 12.1% 150,010 30.4%
Smaller facilities 80,597 5.8% 5,419 1.1%
Total 1,394,603 100.0% 493,123 100.0%

*incl. some under-75s living at home due to IT error

       

Follow us:

Latest stories

  • Philips: Issues with sleep apnea machines less harmful than thought
  • Instructor, student killed in small plane crash on Tuesday
  • Covid hospital patient total jumps 17 percent; New infections rise by 29 percent
  • Supreme Court confirms mother's conviction for girl's fatal fall from Hoogeveen flat
  • Authorities can use hacked encrypted chats for investigations: Supreme Court
  • Sea levels along Dutch coast rising faster: Delft researchers

Top stories

  • Covid hospital patient total jumps 17 percent; New infections rise by 29 percent
  • Video: Two arrested in shocking armed robbery at Tefaf art fair in Maastricht
  • Small plane crashes in Flevoland lake; Rescuers working to save victims
  • Farmers burning hay bales on highways with more nitrogen policy protests expected
  • Health Min. wants to expand euthanasia access to terminally ill children under 12
  • Woman, 73, killed in Zeeland tornado

© 2012-2022, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content